ArticleCancer research2020

Modeling Resistance and Recurrence Patterns of Combined Targeted-Chemoradiotherapy Predicts Benefit of Shorter Induction Period.

David M McClatchy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.